(Q39164396)

English

Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in mice

scientific article published on 23 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Schistosoma mansoni

0 references

author name string

Loc Le

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Weidong Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Souvik Karmakar

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Gul Ahmad

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Workineh Torben

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Afzal A Siddiqui

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

23 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Parasitology Research

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

113

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1195-1200

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

https://scigraph.springernature.com/pub.10.1007/s00436-014-3757-4

0 references

Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Blueprint for schistosomiasis vaccine development

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Trick or treat: the role of vaccines in integrated schistosomiasis control

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Prime-boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Heterologous prime-boost vaccination.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

A research agenda for helminth diseases of humans: The problem of helminthiases

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Current status of vaccines for schistosomiasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

The baboon as a non-human primate model of human schistosome infection

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

A research agenda for helminth diseases of humans: Intervention for control and elimination

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Time to set the agenda for schistosomiasis elimination

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Experimental vaccines in animal models for schistosomiasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Schistosomiasis vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Transforming growth factor-beta and Th17 responses in resistance to primary murine schistosomiasis mansoni.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Evaluation of the health-related quality of life of children in Schistosoma haematobium-endemic communities in Kenya: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Immunopathology of schistosomiasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum).

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3757-4

21 January 2018

Complement and 5-HT increase phosphatidylcholine incorporation into the outer bilayers of Schistosoma mansoni

1 reference

https://pubmed.ncbi.nlm.nih.gov/24452916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

More on the search for a schistosomiasis vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24452916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of Ca(2+)-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni

1 reference

https://pubmed.ncbi.nlm.nih.gov/24452916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospects of vaccination against schistosomiasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24452916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of serotonin (5HT) and complement C3 on the synthesis of the surface membrane precursors of adult Schistosoma mansoni.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24452916

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00436-014-3757-4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39164396&oldid=1810938894"